Medical Journals

The Mitochondrion As a Primary Site of Action of Regulatory Agents Involved in Neuroimmunomodulation.

Authors:
  • Psarra A M G
  • Solakidi S
  • Sekeris C E

From: Foundation for Biomedical Research of the Academy of Greece, Athens, Greece.

Annals of the New York Academy of Sciences

  • Publish Date: Nov 2006
  • ISSN: 0077-8923
  • Volume: 1088
  • Issue:
  • Pages: 12-22
  • Medium: Print
  • Language: English
  • Citation (JAMA): Psarra A M G, Solakidi S, Sekeris C E, et al. The Mitochondrion As a Primary Site of Action of Regulatory Agents Involved in Neuroimmunomodulation.. Ann. N. Y. Acad. Sci. Nov 2006;1088:12-22

Abstract

A major system of neuroimmunomodulation is the hypothalamic-pituitary-adrenocortical (HPA) axis, acting through glucocorticoids and their intracellular signaling components, exerting both stimulatory and inhibitory effects on the immune reaction. Glucocorticoids inhibit the production of proinflammatory cytokines by interacting with nuclear transcription factors (nuclear factor [NF]-kappaB, activated protein [AP]-1) and induce the production of several anti-inflammatory cytokines by gene activation. In some cells and/or in extreme stress conditions, apoptosis is evoked. In most processes related to neuroimmunomodulation a prominent role is emerging for mitochondria. These organelles generate more than 90% of the cell’s energy requirements through oxidative phosphorylation (OXPHOS), which is regulated by several agents, including steroid and thyroid hormones. These hormones are inducers of nuclear and mitochondrial OXPHOS gene transcription and they exert a primary action not only on nuclear but also on mitochondrial genes by way of cognate receptors. Recently, additional nuclear transcription factors involved in neuroimmunomodulation have been detected in mitochondria (NF-kappaB, AP-1, p53, calcium/cAMP response element binding protein [CREB]), and binding sites of these and putative binding sites of other nuclear transcription factors have been identified in the mitochondrial genome. The interaction of these factors with mitochondrial regulatory proteins, with receptors and with the genome has been shown and, in some cases, modulation of mitochondrial transcription was observed with possible effects on energy yield. The mitochondria store a host of critical apoptotic activators and inhibitors in their intermembrane space and the release of these factors could be another possible mode of action of the mitochondrially translocated regulatory agents and receptors.

Mesh Headings (Keywords): Animals, Apoptosis, Humans, Mitochondria, Neuroimmunomodulation, Oxidative Phosphorylation, Receptors, Steroid, Transcription Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17192553


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.